Key Points Rescheduling could expand Tilray’s U.S. medical cannabis opportunity. U.S. cannabis operators could benefit more immediately from rescheduling. Tilray looks stronger, but federal reform remains uncertain. 10 stocks we like better than Tilray Brands › President Donald Trump directed federal officials to move quickly on marijuana rescheduling, and that effort just survived another legal challenge. Last week, a federal appeals court rejected a request from marijuana opponents to temporarily block the administration from moving forward with broader rescheduling while their lawsuits are considered.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.